A 2014 study published in The New England Journal of Medicine found that for each one percent increase in adenoma detection rate (ADR) – a measurement that indicates how carefully a colonoscopy is performed – there is a three percent decrease in colorectal cancer risk. A 2020 study published in the Annals of American Medicine found patients who received just one negative colonoscopy were at a lower risk for colorectal cancer for up to 17.4 years – but only if they had an exam with an ADR of more than 20 percent.
AMSURG surgery centers measure quality performance through GIQuIC – and from ADR to withdrawal times, they perform above industry benchmarks. Our physician partners’ ADRs also improve over time with participation in GIQuIC.
Advocacy for Earlier Colonoscopies
AMSURG and its ASCs also advocate for earlier access to high-quality colonoscopies.
Why? In 2019 alone, our partners identified more than 300 cases of colorectal cancer in patients under the age of 50. We removed polyps from more than 24,000 patients who had not yet reached age 50.
Providing patients earlier access to high-quality screens saves lives.